Real-world data (RWD) are an increasingly important input into the pharmaceutical R&D process as shown by countries like the USA or Finland. As the availability of and access to Swiss RWD is rather limited, the question arises whether this creates a burden for pharmaceutical R&D in Switzerland....

Despite tremendous growth in the volume of new scientific and technological knowledge, the popular press has recently raised concerns that disruptive innovative activity is slowing. These dire prognoses were mainly driven by Park et al. (2023), a Nature publication that uses decades of data and...

We examine whether 'pioneer' regions - early leaders in generating new ideas in emerging scientific fields - develop and maintain an innovation advantage in the same fields over time. Our analysis covers 24 disruptive technologies (e.g. AI, cloud computing) in thousands of OECD regions over 20...